A PHASE 2 TRIAL OF THE EFFICACY AND SAFETY OF THE ALPHA7 AGONIST ABT-126 AS AN ADD-ON TREATMENT IN MILD-TO-MODERATE ALZHEIMER'S DEMENTIA
2014
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
5
Citations
NaN
KQI